BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29288746)

  • 1. A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Custodio RJ; Woo T; Seo JW; Jang CG; Yang JS; Yoon YM; Lee YS; Kim HJ; Cheong JH
    Behav Brain Res; 2018 Apr; 341():122-128. PubMed ID: 29288746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Behav Brain Res; 2017 Jan; 317():494-501. PubMed ID: 27737791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microinjections of a dopamine D1 receptor antagonist into the ventral tegmental area block the expression of cocaine conditioned place preference in rats.
    Galaj E; Manuszak M; Arastehmanesh D; Ranaldi R
    Behav Brain Res; 2014 Oct; 272():279-85. PubMed ID: 25017572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The abuse potential of two novel synthetic cathinones with modification on the alpha-carbon position, 2-cyclohexyl-2-(methylamino)-1-phenylethanone (MACHP) and 2-(methylamino)-1-phenyloctan-1-one (MAOP), and their effects on dopaminergic activity.
    Botanas CJ; Yoon SS; de la Peña JB; Dela Peña IJ; Kim M; Woo T; Seo JW; Jang CG; Park KT; Lee YH; Lee YS; Kim HJ; Cheong JH
    Pharmacol Biochem Behav; 2017 Feb; 153():160-167. PubMed ID: 28063946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats.
    Sellings LH; McQuade LE; Clarke PB
    Neuroscience; 2006 Sep; 141(3):1457-68. PubMed ID: 16753267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of D1- and D2-like dopamine receptors in the dentate gyrus in the acquisition, expression, and extinction of the morphine-induced conditioned place preference in rats.
    Katebi N; Farahimanesh S; Fatahi Z; Zarrabian S; Haghparast A
    Behav Brain Res; 2018 Nov; 353():185-193. PubMed ID: 30053460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential.
    Custodio RJP; Sayson LV; Botanas CJ; Abiero A; You KY; Kim M; Lee HJ; Yoo SY; Lee KW; Lee YS; Seo JW; Ryu IS; Kim HJ; Cheong JH
    Addict Biol; 2020 Nov; 25(6):e12850. PubMed ID: 31749223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modafinil-induced conditioned place preference via dopaminergic system in mice.
    Nguyen TL; Tian YH; You IJ; Lee SY; Jang CG
    Synapse; 2011 Aug; 65(8):733-41. PubMed ID: 21157933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential rewarding and reinforcing effects of the substituted benzofurans 2-EAPB and 5-EAPB in rodents.
    Sayson LV; Custodio RJP; Ortiz DM; Lee HJ; Kim M; Jeong Y; Lee YS; Kim HJ; Cheong JH
    Eur J Pharmacol; 2020 Oct; 885():173527. PubMed ID: 32871174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in dopamine binding and modafinil conditioned place preference in mice.
    Bernardi RE; Broccoli L; Spanagel R; Hansson AC
    Drug Alcohol Depend; 2015 Oct; 155():37-44. PubMed ID: 26342627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of a dopamine receptor complex amplifies the actions of cocaine.
    Perreault ML; Hasbi A; Shen MYF; Fan T; Navarro G; Fletcher PJ; Franco R; Lanciego JL; George SR
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1366-1377. PubMed ID: 27480020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward.
    Sagheddu C; Scherma M; Congiu M; Fadda P; Carta G; Banni S; Wood JT; Makriyannis A; Malamas MS; Pistis M
    Neuropharmacology; 2019 Jan; 144():327-336. PubMed ID: 30439418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of D1/D2 dopamine receptors in the CA1 region of the rat hippocampus in the rewarding effects of morphine administered into the ventral tegmental area.
    Esmaeili MH; Kermani M; Parvishan A; Haghparast A
    Behav Brain Res; 2012 May; 231(1):111-5. PubMed ID: 22426507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel psychoactive substance 25E-NBOMe induces reward-related behaviors via dopamine D1 receptor signaling in male rodents.
    Kim YJ; Kook WA; Ma SX; Lee BR; Ko YH; Kim SK; Lee Y; Lee JG; Lee S; Kim KM; Lee SY; Jang CG
    Arch Pharm Res; 2024 Apr; 47(4):360-376. PubMed ID: 38551761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Abuse Potential of Novel Synthetic Phencyclidine Derivative 1-(1-(4-Fluorophenyl)Cyclohexyl)Piperidine (4'-F-PCP) in Rodents.
    Ryu IS; Kim OH; Lee YE; Kim JS; Li ZH; Kim TW; Lim RN; Lee YJ; Cheong JH; Kim HJ; Lee YS; Steffensen SC; Lee BH; Seo JW; Jang EY
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels.
    Abiero A; Botanas CJ; Custodio RJ; Sayson LV; Kim M; Lee HJ; Kim HJ; Lee KW; Jeong Y; Seo JW; Ryu IS; Lee YS; Cheong JH
    Psychopharmacology (Berl); 2020 Mar; 237(3):757-772. PubMed ID: 31828394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orexin A in the ventral tegmental area induces conditioned place preference in a dose-dependent manner: involvement of D1/D2 receptors in the nucleus accumbens.
    Taslimi Z; Arezoomandan R; Omranifard A; Ghalandari-Shamami M; Riahi E; Vafaei AA; Rashidy-Pour A; Haghparast A
    Peptides; 2012 Oct; 37(2):225-32. PubMed ID: 22885169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baclofen blocks the acquisition and expression of mitragynine-induced conditioned place preference in rats.
    Yusoff NHM; Mansor SM; Müller CP; Hassan Z
    Behav Brain Res; 2018 Jun; 345():65-71. PubMed ID: 29499286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two newly-emerging substituted phenethylamines MAL and BOD induce differential psychopharmacological effects in rodents.
    Custodio RJP; Sayson LV; Botanas CJ; Abiero A; Kim M; Lee HJ; Ryu HW; Lee YS; Kim HJ; Cheong JH
    J Psychopharmacol; 2020 Sep; 34(9):1056-1067. PubMed ID: 32648801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.